Literature DB >> 35241540

Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach.

Vittorio Altomare1, Paolo Orsaria2, Antonella Grasso1, Lorenza Caggiati1, Edy Ippolito3, Francesco Pantano4, Matteo Sammarra5, Carlo Altomare5, Giuseppe Perrone6, Gabriella Gullotta6, Rita Carino1.   

Abstract

BACKGROUND/AIM: The prediction of a sub-areolar tissue infiltration in breast cancer (BC) patients could be helpful in selecting the best functional outcome according to several reconstructive oncoplastic or radical techniques. This study aims to evaluate the diagnostic performance of preoperative ultrasound (US) guided sub-areolar biopsy (SAB) in detecting occult nipple involvement, in comparison with the definitive pathological examination of tissue after surgery. PATIENTS AND METHODS: We prospectively recorded clinical and pathological data of 46 consecutive patients scheduled for breast conserving surgery or nipple-areola sparing mastectomy. All cases underwent preoperative SAB and the results were compared with the histopathology of the dissected tumors and their biological characteristics. All parameters were correlated with nipple involvement by univariate and multivariate analysis.
RESULTS: The sensitivity, specificity, overall accuracy, positive predictive value, and negative predictive value of the SAB examination for nipple staging were 60%, 97.5%, 75% and 95.2%, respectively. According to the clinicopathological features, the bivariate analysis did not show a significant interaction between patient age, tumor size or type, lymph node status, lymphatic vascular invasion, histologic grade, ER, PR, Ki-67 status, HER2 amplification, multifocal or multicentric disease and positive NAC assessment (p>0.05).
CONCLUSION: A preoperative sample of retroareolar tissue obtained by US-guided biopsy could be considered a reproducible, mini-invasive diagnostic procedure useful to facilitate immediate breast reconstruction with implants or through conservative oncoplastic approaches, thereby guiding clinical practice. Copyright
© 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Breast cancer; core needle biopsy; immediate reconstruction; nipple areola sparing; oncoplastic surgery

Mesh:

Year:  2022        PMID: 35241540      PMCID: PMC8931870          DOI: 10.21873/invivo.12771

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  42 in total

1.  Clinical and radiological predictors of nipple-areola complex involvement in breast cancer patients.

Authors:  Marta D'Alonzo; Laura Martincich; Nicoletta Biglia; Alberto Pisacane; Furio Maggiorotto; Giovanni De Rosa; Filippo Montemurro; Franziska Kubatzki; Piero Sismondi; Riccardo Ponzone
Journal:  Eur J Cancer       Date:  2012-05-28       Impact factor: 9.162

2.  Malignant invasion of the nipple-areolar complex of the breast: usefulness of breast MRI.

Authors:  Ji Yoon Moon; Yun-Woo Chang; Eun Hye Lee; Dae Young Seo
Journal:  AJR Am J Roentgenol       Date:  2013-08       Impact factor: 3.959

3.  Tumor-to-Nipple Distance as a Predictor of Nipple Involvement: Expanding the Inclusion Criteria for Nipple-Sparing Mastectomy.

Authors:  Briar L Dent; Jake A Miller; Daniel J Eden; Alexander Swistel; Mia Talmor
Journal:  Plast Reconstr Surg       Date:  2017-07       Impact factor: 4.730

4.  Involvement of nipple and areola in early breast cancer.

Authors:  T Morimoto; K Komaki; K Inui; A Umemoto; H Yamamoto; K Harada; K Inoue
Journal:  Cancer       Date:  1985-05-15       Impact factor: 6.860

Review 5.  Predictive factors of nipple involvement in breast cancer: a systematic review and meta-analysis.

Authors:  Hanwen Zhang; Yaming Li; Meena S Moran; Bruce G Haffty; Qifeng Yang
Journal:  Breast Cancer Res Treat       Date:  2015-04-19       Impact factor: 4.872

6.  The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin-sparing mastectomy.

Authors:  C Laronga; B Kemp; D Johnston; G L Robb; S E Singletary
Journal:  Ann Surg Oncol       Date:  1999-09       Impact factor: 5.344

7.  Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging.

Authors:  Stefano Ciatto; Beniamino Brancato; Gabriella Risso; Daniela Ambrogetti; Paolo Bulgaresi; Cristina Maddau; Patricia Turco; Nehmat Houssami
Journal:  Breast Cancer Res Treat       Date:  2006-10-11       Impact factor: 4.872

8.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

Authors:  L C Hartmann; D J Schaid; J E Woods; T P Crotty; J L Myers; P G Arnold; P M Petty; T A Sellers; J L Johnson; S K McDonnell; M H Frost; R B Jenkins
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

9.  Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential.

Authors:  Paolo Orsaria; Antonella Grasso; Rita Carino; Emanuele Caredda; Matteo Sammarra; Carlo Altomare; Carla Rabitti; Gabriella Gullotta; Giuseppe Perrone; Francesco Pantano; Oreste Claudio Buonomo; Vittorio Altomare
Journal:  Tumori       Date:  2019-08-27       Impact factor: 2.098

10.  Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques.

Authors:  Joerg Heil; Sherko Kümmel; Benedikt Schaefgen; Stefan Paepke; Christoph Thomssen; Geraldine Rauch; Beyhan Ataseven; Regina Große; Volker Dreesmann; Thorsten Kühn; Sibylle Loibl; Jens-Uwe Blohmer; Gunter von Minckwitz
Journal:  Br J Cancer       Date:  2015-11-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.